- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 04-12-2025: Press Release
04-12-2025 | 01:17 pm
04-12-2025 | 01:17 pm
Lupin partnered with Valorum Biologics for exclusive U.S. commercialization of biosimilar Armlupeg™ (pegfilgrastim-unne). Lupin handles manufacturing, receiving an upfront license fee and royalties on net sales, strengthening its U.S. biosimilars presence.
No comments yet. Be the first to comment!